These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 26774083)
21. Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 Cells. Nabi R; Alvi SS; Shah A; Chaturvedi CP; Iqbal D; Ahmad S; Khan MS Life Sci; 2019 Oct; 235():116823. PubMed ID: 31476307 [TBL] [Abstract][Full Text] [Related]
22. Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions. Wetzels S; Vanmierlo T; Scheijen JLJM; van Horssen J; Amor S; Somers V; Schalkwijk CG; Hendriks JJA; Wouters K Front Immunol; 2019; 10():855. PubMed ID: 31068938 [TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Rojas A; Añazco C; González I; Araya P Carcinogenesis; 2018 Apr; 39(4):515-521. PubMed ID: 29373651 [TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease. Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680 [TBL] [Abstract][Full Text] [Related]
25. Glyoxal induced glycative insult suffered by immunoglobulin G and fibrinogen proteins: A comparative physicochemical characterization to reveal structural perturbations. Alouffi S; Shahab U; Khan S; Khan M; Khanam A; Akasha R; Shahanawaz SD; Arif H; Tahir IK; Rehman S; Ahmad S Int J Biol Macromol; 2022 Apr; 205():283-296. PubMed ID: 35192903 [TBL] [Abstract][Full Text] [Related]
26. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions. Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227 [TBL] [Abstract][Full Text] [Related]
27. Polyphenols and AGEs/RAGE axis. Trends and challenges. González I; Morales MA; Rojas A Food Res Int; 2020 Mar; 129():108843. PubMed ID: 32036875 [TBL] [Abstract][Full Text] [Related]
29. Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants. Kovacic P; Somanathan R J Recept Signal Transduct Res; 2011 Oct; 31(5):332-9. PubMed ID: 21929288 [TBL] [Abstract][Full Text] [Related]
30. Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds. Baig MH; Jan AT; Rabbani G; Ahmad K; Ashraf JM; Kim T; Min HS; Lee YH; Cho WK; Ma JY; Lee EJ; Choi I Sci Rep; 2017 Jul; 7(1):5916. PubMed ID: 28725008 [TBL] [Abstract][Full Text] [Related]
31. Associations of dicarbonyl stress with complement activation: the CODAM study. Xin Y; Hertle E; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; van Greevenbroek MMJ Diabetologia; 2020 May; 63(5):1032-1042. PubMed ID: 31993713 [TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications. Chen Y; Meng Z; Li Y; Liu S; Hu P; Luo E Mol Med; 2024 Sep; 30(1):141. PubMed ID: 39251935 [TBL] [Abstract][Full Text] [Related]
33. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515 [TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs. Deluyker D; Evens L; Bito V Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551 [TBL] [Abstract][Full Text] [Related]
35. Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study. Csongová M; Scheijen JLJM; van de Waarenburg MPH; Gurecká R; Koborová I; Tábi T; Szökö É; Schalkwijk CG; Šebeková K Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432614 [TBL] [Abstract][Full Text] [Related]
36. Advanced Glycation End Products, Diabetes, and Bone Strength. Yamamoto M; Sugimoto T Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396 [TBL] [Abstract][Full Text] [Related]
37. Probing glycation potential of dietary sugars in human blood by an integrated in vitro approach. Frolova N; Soboleva A; Nguyen VD; Kim A; Ihling C; Eisenschmidt-Bönn D; Mamontova T; Herfurth UM; Wessjohann LA; Sinz A; Birkemeyer C; Frolov A Food Chem; 2021 Jun; 347():128951. PubMed ID: 33493836 [TBL] [Abstract][Full Text] [Related]
38. Towards the control and inhibition of glycation-the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study. Saraiva MA; Borges CM; Florêncio MH J Mass Spectrom; 2006 Oct; 41(10):1346-68. PubMed ID: 17039581 [TBL] [Abstract][Full Text] [Related]
39. Role of advanced glycation end products and insulin resistance in diabetic nephropathy. Parwani K; Mandal P Arch Physiol Biochem; 2023 Feb; 129(1):95-107. PubMed ID: 32730131 [TBL] [Abstract][Full Text] [Related]
40. Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways. Nam HK; Jeong SR; Pyo MC; Ha SK; Nam MH; Lee KW Biol Pharm Bull; 2021; 44(11):1697-1706. PubMed ID: 34719646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]